GHRP: Growth Hormone Secretagogues Explained
By Charles Kamen, MD, board-certified neurologist
growth hormone secretagogues are growth hormone-releasing peptides frequently used in combination protocols. Dr. Charles Kamen, MD, board-certified neurologist at LiveNow Longevity in Las Vegas, offers these peptides as part of comprehensive peptide therapy protocols. Individual results vary.
What Are growth hormone secretagogues
Growth hormone secretagogues are compounds — including GHRH analogs and growth-hormone-releasing peptides — that stimulate the pituitary gland to produce and secrete more growth hormone. It has a long half-life due to binding to albumin in the bloodstream. [1]
Ipamorelin is a selective growth hormone secretagogue (GHS) that stimulates growth hormone release through a different pathway — the ghrelin receptor. It is known for producing fewer side effects than non-selective growth hormone secretagogues. [2]
How They Work Together
Combining growth hormone secretagogues creates a synergistic effect. growth hormone secretagogues stimulates the pituitary directly; growth hormone secretagogues adds stimulation through the ghrelin pathway. [3]
This combination typically produces less pronounced side effects than growth hormone injection while still elevating growth hormone levels.
Benefits of growth hormone secretagogues/growth hormone secretagogues Therapy
Patients using growth hormone secretagogues/growth hormone secretagogues report various benefits:
- Improved sleep quality and duration
- Increased energy and reduced fatigue
- Enhanced recovery from exercise and injury
- Potential improvement in body composition (lean tissue vs. fat)
- Support for skin elasticity and tissue health
- Improved mood and cognitive function reported by some patients
Evidence Base
Research supports growth hormone-releasing peptide benefits in various populations. Studies in middle-aged and older adults show increased IGF-1 levels, improved body composition, and enhanced physical performance. [4]
However, individual responses vary, and results depend on age, health status, diet, exercise, and other factors.
Dosing and Administration
growth hormone secretagogues/growth hormone secretagogues are typically administered via subcutaneous injection. Common protocols involve 3-5 injections per week. [5]
Dr. Kamen determines appropriate dosing based on patient goals, health status, and response to therapy. Starting doses are conservative, with gradual titration based on tolerance and results.
Key Takeaways
- growth hormone secretagogues stimulates growth hormone via GHRH pathway; growth hormone secretagogues via ghrelin receptor
- Combined use produces synergistic growth hormone elevation
- Benefits include improved sleep, energy, recovery, and body composition
- Subcutaneous injection 3-5 times weekly is standard protocol
- Results depend on age, health status, diet, and exercise
- Dr. Kamen monitors IGF-1 and clinical response throughout therapy
Common Questions
Is growth hormone secretagogues/growth hormone secretagogues the same as growth hormone injection?
No. These peptides stimulate your own pituitary to release growth hormone. HGH injection provides exogenous growth hormone directly. Peptide therapy creates a more physiological increase.
How long before I notice results from growth hormone secretagogues/growth hormone secretagogues?
Most patients notice improved sleep within the first few weeks. Other benefits typically emerge over 2-3 months of consistent therapy. Individual responses vary.
What are the side effects?
Reported side effects include water retention, numbness/tingling, and appetite changes. These are typically mild and dose-dependent. Dr. Kamen monitors for adverse effects.
Can I use growth hormone secretagogues/growth hormone secretagogues with exercise?
Yes. In fact, combining peptide therapy with resistance training optimizes body composition results. Exercise and adequate protein intake enhance the muscle-building effects.
How long can I stay on growth hormone secretagogues/growth hormone secretagogues?
Treatment protocols vary. Dr. Kamen typically recommends cycling (periods on and off) or ongoing therapy with regular monitoring. Duration depends on individual goals and response.
Will growth hormone secretagogues/growth hormone secretagogues cause cancer?
Current evidence does not support a direct link between growth hormone-releasing peptides and cancer development. However, growth hormone can stimulate existing cancer cell growth. Cancer screening before initiating therapy is standard at our Las Vegas clinic.
growth hormone secretagogues/growth hormone secretagogues represent a physician-supervised approach to growth hormone optimization. Schedule a consultation with Dr. Kamen to determine whether this peptide protocol is appropriate for your health and longevity goals.
References
- Sackmann-Sala L, Ding J, Frohman LA, et al. Growth Horm IGF Res. 2009;19(6):471-477. (Activation of the GH/IGF-1 axis by CJC-1295, a long-acting GHRH analog).
- Raun K, et al. Eur J Endocrinol. 1998;139(5):552-561. (Ipamorelin, the first selective growth hormone secretagogue).
- Bowers CY, et al. J Clin Endocrinol Metab. 1990;70(4):975-982. (GH-releasing peptide stimulates GH release in normal men and acts synergistically with GHRH).
- Nass R, et al. Ann Intern Med. 2008;149(9):601-611. (Oral ghrelin mimetic improves body composition and IGF-1 in healthy older adults, RCT).
- Ionescu M, Frohman LA. J Clin Endocrinol Metab. 2006;91(12):4792-4797. (Pulsatile GH secretion during continuous stimulation by CJC-1295).
Wondering what’s right for you?
Get a straight answer from board-certified neurologist Dr. Charles Kamen, MD. The evaluation is $88 and is applied toward your protocol if you continue care.